Archit Organosys Ltd Stock Price Today (NSE: ARCHITORG)

Archit Organosys Ltd

52.02+1.80 (+3.58%)
Market Open

Fundamental Score

...

Archit Organosys Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Archit Organosys Ltd share price today is 52.02, up +3.58% on NSE/BSE as of 18 June 2026. Archit Organosys Ltd (ARCHITORG) is a Small-cap company in the Commodity Chemicals sector with a market capitalisation of 82.68 (Cr). The 52-week high for ARCHITORG share price is 57.80 and the 52-week low is 34.00. At a P/E ratio of 12.51x, ARCHITORG is currently trading below its industry average P/E of 20.98x. The company has a Return on Equity (ROE) of 7.62% and a debt-to-equity ratio of 0.39.

Archit Organosys Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
57.80
Low
46.00
Volume
29.8K
Change
-8.78%

Archit Organosys Ltd share price chart: -8.78% return over the past month. 52-week high ₹57.80, 52-week low ₹34.00.

Archit Organosys Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
50.8553.0050.0052.0213.87K (Cr)
50.0050.7948.5050.229.87K (Cr)
51.4851.7549.0049.9212.14K (Cr)
51.4951.5950.0250.179.00K (Cr)
51.7951.7950.0051.0112.50K (Cr)
52.8052.8050.0051.4115.70K (Cr)
48.9049.9947.5049.6210.66K (Cr)
47.9049.0047.7648.9221.07K (Cr)
46.0047.2846.0047.015.39K (Cr)
47.0848.0046.0046.7730.59K (Cr)

Archit Organosys Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
50.0053.0048.5052.02+4.04%
51.6157.8046.0049.92-3.27%
36.3456.2136.3451.61+42.02%
38.1039.8934.0036.16-5.09%
41.7046.7038.0039.08-6.28%
42.8046.1038.0040.01-6.52%
41.5047.2538.5042.67+2.82%
45.2047.7438.5041.64-7.88%
46.1648.6445.0045.53-1.36%
44.6851.4543.5146.45+3.96%
48.0049.0042.2544.68-6.92%
43.5048.5041.0047.23+8.57%

AI Research Briefing

Powered by Gemini · 2026-04-09

Small commodity chemicals player; sector tailwinds, but micro-cap liquidity and valuation are brutal.

Research Confidence
5.0/10Moderate
MICRO-CAP DARK HORSEConsolidation: 1M: -11.51%, 3M: -10.37%, 6M: -9.62%.Expensive: P/E of 127.71 vs. industry P/E of 20.98.

WHAT'S HAPPENING NOW (last 2-4 weeks)

No major catalysts found after live search. Archit Organosys shares are Markets Mojo upgraded the stock from 'Strong Sell' to 'Sell' as of February 3, 2026, citing improved valuation attractiveness.

CORE STORY (THE REAL GAME)

Archit Organosys is a play on the Indian commodity chemicals sector, benefiting from increasing demand across agriculture, construction, and automotive industries. The real game is whether they can scale and maintain margins amidst raw material price volatility and increasing competition.

Why Now
  • Valuation upgrade by MarketsMojo
  • Sector growth projections
  • Land acquisition for future expansion
Potential Catalysts
  • Significant order wins
  • Earnings beat expectations
  • Successful capacity expansion
Key Risks
  • Micro-cap with low liquidity
  • High P/E ratio of 127.71
  • Dependence on imported raw materials
Institutional Activity

Promoter holding steady at 65.39%, no change in FII/DII activity.

Macro Context

Commodity chemicals sector benefits from growth in agriculture, construction, and automotive industries.

Order Book / Expansion

The company formalized an agreement to acquire land in Bhavnagar, India, for ₹105.1 million.

Cash Flow Quality

Free Cash Flow 5Y: ₹50.23 Cr.

3–6 Month Outlook

If Archit Organosys can demonstrate consistent earnings growth and manage its raw material costs effectively, it could be a compelling investment. However, its micro-cap status and high valuation warrant caution.

Primary Thesis Risk

Illiquidity and stretched valuation could lead to a sharp correction.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

7.62%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

10.85%

Returns generated on total capital deployed

Good

Oper. Profit Margin (5Y Avg)

11.31%

Average operating profit margin over 5 years

Good

Dividend Yield

1.24%

Annual dividend as % of current share price

Archit Organosys Ltd Valuation Check

Excellent

Price to Earnings (P/E)

12.51x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

20.98x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

65.39%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

50.98%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

11.24%

Revenue growth vs same quarter last year

Average

Revenue Growth (5-Year CAGR)

10.37%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

44.16%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

50.70%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Good

Debt to Equity Ratio

0.39x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

5.07x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

50.23 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Archit Organosys Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ARCHITORG across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Attractive Valuation (P/E: 12.51 vs Industry: 20.98)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (50.98%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Excellent EPS Growth (44.16% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (50.70% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Strong Interest Coverage (5.07x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Strong Cash Generation (₹50.23 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (65.39%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

1 factors identified

Below-Average Return on Equity (7.62%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Archit Organosys Ltd vs Commodity Chemicals Peers

Peer Comparison - Commodity Chemicals

Compare Archit Organosys Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
63.1/100
52
₹82.68
12.5
Average
7.62%
Poor
10.85%
Average
0.4
Excellent
50.70%
Excellent
10.37%
Good
1.24%
SRF Ltd...
SRF503806
49.8/100
2737
₹86606.52
53.5
Average
10.37%
Average
12.27%
Average
0.3
Excellent
4.40%
Average
15.30%
Excellent
0.25%
14.9/100
775
₹20261.08
62.2
Average
1.20%
Poor
3.96%
Poor
0.3
Excellent
-47.92%
Poor
7.53%
Good
1.38%
57/100
1448
₹17120.52
17.4
Average
15.56%
Good
15.67%
Good
0.7
Good
94.55%
Excellent
17.00%
Excellent
0.74%
52.8/100
516
₹7381.56
11.6
Average
7.08%
Poor
9.57%
Poor
0.0
Excellent
3.30%
Average
8.86%
Good
3.58%
Ghcl Ltd...
GHCL500171
40.4/100
463
₹5520.31
9.7
Average
18.57%
Good
24.19%
Excellent
0.0
Excellent
8.63%
Good
-0.75%
Poor
2.09%
19.7/100
18
₹5397.73
9306.4
Average
2.12%
Poor
2.57%
Poor
0.0
Excellent
173.71%
Excellent
0.00%
24.4/100
222
₹4503.74
-5.93%
Poor
1.83%
Poor
1.0
Good
28.15%
Excellent
0.00%
68.7/100
1972
₹4106.65
43.7
Average
32.05%
Excellent
41.76%
Excellent
0.1
Excellent
38.64%
Excellent
27.58%
Excellent
0.22%
28/100
687
₹3866.17
25774.5
Average
-1.13%
Poor
-0.34%
Poor
0.1
Excellent
8.37%
Good
3.01%
59.7/100
72
₹3614.14
23.9
Average
17.58%
Good
23.34%
Excellent
0.0
Excellent
17.17%
Excellent
12.90%
Good
0.63%

Archit Organosys Ltd PE Ratio History

Historical price-to-earnings ratio for ARCHITORG — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20241.63₹47.7629.3x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Archit Organosys Ltd Dividend History

Annual cash dividends paid by ARCHITORG — dividend yield 1.24%

Financial YearDividends Paid (₹ Cr)
FY 20250.00 Cr
FY 20240.99 Cr
FY 20231.44 Cr
FY 20221.03 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Archit Organosys Ltd Quarterly Performance

Latest quarterly metrics for ARCHITORG — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

11.24%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

50.98%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

10.37%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

50.70%

Compounded annual net profit growth over 5 years

Archit Organosys Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for ARCHITORG — calculated from daily price history

41RSI 14
Neutral — RSI 41

Momentum is balanced — neither overbought nor oversold.

SMA 50
46
▲ Price above SMA 50 — Short-term bullish
SMA 200
44
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
35K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Archit Organosys Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Archit Organosys Ltd (ARCHITORG) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Archit Organosys Ltd

About ARCHITORG (Archit Organosys Ltd)

Archit Organosys Ltd is a dynamic entity deeply embedded in the global commodity chemical landscape. It specializes in the creation and distribution of a diverse portfolio of chemi...cal solutions that serve as the foundational building blocks for numerous industries. ARCHITORG's operations are centered around the meticulous crafting of essential chemical compounds, supplying the raw materials that fuel advancements across sectors ranging from agriculture to personal care. The company meticulously oversees every stage of its supply chain, ensuring the consistent delivery of high-quality products that meet stringent international standards. Through a combination of cutting-edge manufacturing techniques and a commitment to sustainable practices, ARCHITORG strives to be a reliable and responsible partner for its customers worldwide. At the heart of ARCHITORG's product offerings are vital chemical intermediates and specialty chemicals tailored for specific applications. Key products include monochloroacetic acid (MCA) and its derivative, sodium monochloroacetate (SMCA), critical ingredients in the synthesis of agrochemicals, cosmetic surfactants, oil drilling fluids, and plastic additives. Beyond these core products, ARCHITORG also offers a range of carefully formulated organic chemicals, high-performance pigments, and specialty derivatives, providing a spectrum of solutions for diverse industrial needs. The company further strengthens its market position through the production of adhesives and sealants under its proprietary AOL brand, offering reliable bonding and sealing solutions across construction and manufacturing sectors. ARCHITORG's global presence extends its reach beyond national boundaries, catering to a broad spectrum of clients across international markets. With a strong focus on customer satisfaction and a commitment to building long-term partnerships, the company strives to provide tailored solutions and exceptional service to its diverse clientele. Formerly known as Shri Chlochem Limited, ARCHITORG has undergone a transformative evolution, building upon its legacy of chemical expertise to become a leading player in the commodity chemical industry. The company continues to invest in research and development, exploring innovative solutions and expanding its product portfolio to meet the ever-evolving needs of its global customers.

Company Details

Symbol:ARCHITORG
Industry:Commodity Chemicals
Sector:Commodity Chemicals

Key Leadership

Mr. Kandarp Krishnakant Amin
Chairman
Ms. Archana Kandarp Amin
Whole-Time Director
Mr. Archit Kandarpbhai Amin
Whole Time Director

Corporate Events

Recent
Ex-Dividend Date

ARCHITORG Share Price: Frequently Asked Questions

What is the current share price of Archit Organosys Ltd?

Archit Organosys Ltd (ARCHITORG) trades at ₹52.02 on NSE and BSE. Market cap ₹82.68 (Cr). Educational data only.

What is the P/E ratio of Archit Organosys Ltd?

Archit Organosys Ltd has a P/E of 12.51x vs industry average 20.98x.

What is the Bull Run score for Archit Organosys Ltd?

Archit Organosys Ltd has a Bull Run score of 63.1/100 based on 25+ financial parameters.

Does Archit Organosys Ltd pay dividends?

Archit Organosys Ltd has a dividend yield of 1.24%. Past dividends don't guarantee future payments.

What is the ROE of Archit Organosys Ltd?

Archit Organosys Ltd has ROE of 7.62%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Archit Organosys Ltd?

Archit Organosys Ltd has debt-to-equity of 0.39.

Is Archit Organosys Ltd a good investment?

Bull Run gives Archit Organosys Ltd a score of 63.1/100. This is not investment advice — consult a SEBI-registered advisor.